Congress orders independent study of AI risks to seniors—before regulating
S. 4916 — Aging with Artificial Intelligence Act of 2026 · Filed by Mark Kelly (D-AZ) · 3 cosponsors · Introduced Jun 24, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Department of Health and Human Services to commission a study from the National Academies of Sciences, Engineering, and Medicine examining how artificial intelligence systems (chatbots, voice assistants, health monitors, robotic devices) affect people age 65 and older. The study will analyze both benefits (companionship, health information, daily living support) and risks (scams, fraud, misinformation, overreliance), and will include recommendations on safety, privacy, and accessibility. A second provision establishes ongoing research coordination at the National Institute on Aging to disseminate best practices.
Why we flagged it
The bill's core function is commissioning independent research and establishing a coordination mechanism to study AI effects on older adults. It is not a regulatory mandate or industry carve-out, but rather a fact-finding and best-practice dissemination tool.
What the text implies
- Study findings may inform future regulatory action by FTC, CMS, or FDA on AI safety in health/financial contexts, potentially constraining product design or requiring disclosure/consent mechanisms.
- Consultation requirement includes industry representatives, creating a forum where AI companies can shape the research agenda and frame risks/benefits narratives before regulation emerges.
- Emphasis on 'accessibility' and 'human oversight' may presage future mandates for explainability, human-in-the-loop design, or accessibility compliance in AI products targeting older adults.
- Research on 'overreliance' and 'substitution for human interaction' may support future arguments for limiting AI use in caregiving or clinical contexts, affecting telehealth and remote monitoring markets.
Who it affects
Older adults gain from independent, evidence-based research into AI risks and benefits specific to their needs, informing future policy and product design. The study addresses real harms (financial exploitation, health misinformation) and accessibility gaps without imposing immediate restrictions, allowing informed regulation later.
Who stands to gain
- AI and software companies (regulatory intelligence and early influence on research framing)
- National Academies of Sciences, Engineering, and Medicine (contract award)
- Research institutions and universities (downstream research funding)
Named in the bill
Department of Health and Human Services (HHS), National Institute on Aging (NIA), National Academies of Sciences, Engineering, and Medicine, National Institute on Mental Health (NIMH), National Institute of Standards and Technology (NIST), Federal Trade Commission (FTC), Senate Committee on Health, Education, Labor, and Pensions, Senate Special Committee on Aging, House Committee on Energy and Commerce, VRSN (Verisign), AMD (Advanced Micro Devices), HPE (Hewlett Packard Enterprise) — and 2 more
Where it stands
3 cosponsors: 2 Republicans, 1 Democrats.
- Jun 24, 2026 — Introduced · Congress.gov: “Introduced in Senate”
- Jun 24, 2026 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
3 lobbying clients named this bill on 4 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $5,993,000 in lobbying spend. A filing names 103 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 61% of bills with at least one filing.
Mark Kelly, the sponsor, reported $48,750 in PAC receipts in the 2026 cycle.
- American Medical Association — $5,643,000 on 2 filings
- American Psychological Association Services Inc.(fka American Psychological Assn — $340,000 on 1 filing
- The Alliance for Secure Ai Action — $10,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the full bill text on Jul 3, 2026; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Congress orders independent study of AI risks to seniors—before regulating” QuorumCivic. https://share.quorumcivic.app/bill/119/s4916 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.